Standard BioTools Total Long Term Liabilities 2010-2024 | LAB
Standard BioTools total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
| Standard BioTools Annual Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $75 |
| 2023 | $51 |
| 2022 | $117 |
| 2021 | $131 |
| 2020 | $131 |
| 2019 | $78 |
| 2018 | $194 |
| 2017 | $223 |
| 2016 | $224 |
| 2015 | $225 |
| 2014 | $228 |
| 2013 | $3 |
| 2012 | $1 |
| 2011 | $2 |
| 2010 | $195 |
| 2009 | $15 |
| Standard BioTools Quarterly Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2024-12-31 | $75 |
| 2024-09-30 | $72 |
| 2024-06-30 | $75 |
| 2024-03-31 | $79 |
| 2023-12-31 | $51 |
| 2023-09-30 | $108 |
| 2023-06-30 | $111 |
| 2023-03-31 | $114 |
| 2022-12-31 | $117 |
| 2022-09-30 | $120 |
| 2022-06-30 | $125 |
| 2022-03-31 | $203 |
| 2021-12-31 | $131 |
| 2021-09-30 | $136 |
| 2021-06-30 | $127 |
| 2021-03-31 | $129 |
| 2020-12-31 | $131 |
| 2020-09-30 | $128 |
| 2020-06-30 | $111 |
| 2020-03-31 | $113 |
| 2019-12-31 | $78 |
| 2019-09-30 | $73 |
| 2019-06-30 | $74 |
| 2019-03-31 | $75 |
| 2018-12-31 | $194 |
| 2018-09-30 | $191 |
| 2018-06-30 | $188 |
| 2018-03-31 | $187 |
| 2017-12-31 | $223 |
| 2017-09-30 | $221 |
| 2017-06-30 | $220 |
| 2017-03-31 | $223 |
| 2016-12-31 | $224 |
| 2016-09-30 | $225 |
| 2016-06-30 | $225 |
| 2016-03-31 | $225 |
| 2015-12-31 | $225 |
| 2015-09-30 | $227 |
| 2015-06-30 | $227 |
| 2015-03-31 | $228 |
| 2014-12-31 | $228 |
| 2014-09-30 | $229 |
| 2014-06-30 | $229 |
| 2014-03-31 | $232 |
| 2013-12-31 | $3 |
| 2013-09-30 | $2 |
| 2013-06-30 | $2 |
| 2013-03-31 | $2 |
| 2012-12-31 | $1 |
| 2012-09-30 | $1 |
| 2012-06-30 | $1 |
| 2012-03-31 | $1 |
| 2011-12-31 | $2 |
| 2011-09-30 | $4 |
| 2011-06-30 | $6 |
| 2011-03-31 | $7 |
| 2010-12-31 | $195 |
| 2010-09-30 | $12 |
| 2010-06-30 | |
| 2010-03-31 | |
| 2009-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.456B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||